Indexation of Russian manufacturers' maximum prices for essential medicines.


Legal Update No. 193

Goltsblat BLP advises that, on 13 November 2010, information was posted on the website of the Ministry for Health and Social Development of Russia ( by the Department for State Regulation of Medicaments Handling concerning indexation of Russian manufacturers’ maximum prices for essential medicines.

Accordingly, maximum manufacturers’ prices registered before 26 October 2010 are to be indexed to an inflation rate of 8%, as set for 2011 by Federal law 308 – FZ “On the Federal Budget for 2010 and for the plan period of 2011 and 2012”.

The Department emphasises particularly that indexation does not apply to the maximum manufacturers’ prices of medicines produced and released into circulation before 11 November 2010.

We believe “release into circulation” here means initial disposal of the goods by the manufacturer.

For additional information, please contact :

Nina Belozertseva, Senior Associate, Healthcare and Pharmaceuticals,Goltsblat BLP,
T.: +7 (495) 287 44 44,

Contact details


If you would like to receive our legal alerts and updates highlighting current legal issues relevant to your areas of interest and providing expert commentary by our lawyers, please click on "Sign Up" and fill out the form.